Hussman Strategic Advisors Inc. Makes New $2.38 Million Investment in Select Medical Holdings Co. (NYSE:SEM)

Hussman Strategic Advisors Inc. purchased a new stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 126,000 shares of the health services provider's stock, valued at approximately $2,375,000. Hussman Strategic Advisors Inc. owned about 0.10% of Select Medical as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in SEM. KBC Group NV increased its holdings in Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider's stock valued at $455,000 after buying an additional 563 shares during the last quarter. Swiss National Bank grew its position in shares of Select Medical by 0.4% during the 3rd quarter. Swiss National Bank now owns 215,900 shares of the health services provider's stock valued at $7,528,000 after acquiring an additional 800 shares during the period. Quarry LP bought a new position in Select Medical in the 3rd quarter worth $30,000. Sippican Capital Advisors lifted its position in Select Medical by 7.3% during the fourth quarter. Sippican Capital Advisors now owns 13,354 shares of the health services provider's stock valued at $252,000 after purchasing an additional 912 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D grew its holdings in Select Medical by 2.2% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 56,719 shares of the health services provider's stock valued at $1,069,000 after purchasing an additional 1,234 shares during the period. Institutional investors own 89.48% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on SEM shares. Royal Bank of Canada lowered their price objective on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research report on Monday. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target on the stock in a report on Monday. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday. Finally, UBS Group lowered their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $27.25.

Select Medical Price Performance

SEM stock traded up $0.85 during midday trading on Monday, hitting $18.53. The company's stock had a trading volume of 815,077 shares, compared to its average volume of 858,307. Select Medical Holdings Co. has a 12 month low of $16.20 and a 12 month high of $40.98. The company has a 50 day moving average of $19.09 and a two-hundred day moving average of $27.91. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market capitalization of $2.40 billion, a price-to-earnings ratio of 11.26, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.50 billion. On average, analysts expect that Select Medical Holdings Co. will post 1.17 EPS for the current year.

Select Medical Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.35%. The ex-dividend date is Monday, March 3rd. Select Medical's dividend payout ratio is presently 30.30%.

Insiders Place Their Bets

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.